Generating real-world evidence from digital pathology data: an interview with Ross Cantor, Proscia

The digitization of health care has revolutionized the way we collect and utilize real-world data (RWD), creating new ways to generate real-world evidence (RWE) to inform medical research, personalize health care, and ultimately, optimize patient outcomes. In this interview we speak with Ross Cantor, Vice President of Data Strategy & Partnerships at Proscia, to learn more about digital pathology data as an emerging source of RWD. We connected with Ross on the heels of Proscia’s announcement of FDA 510(k) clearance for Concentriq® AP-Dx, a milestone that can help to accelerate the adoption of digital pathology and, by extension, the generation...